Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 10/2017

01-10-2017 | Original Paper

Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV: A “Seek, Test, Treat, and Retain” Harmonization Consortium

Authors: Kelsey B. Loeliger, Mary L. Biggs, Rebekah Young, David W. Seal, Curt G. Beckwith, Irene Kuo, Michael S. Gordon, Frederick L. Altice, Lawrence J. Ouellet, William E. Cunningham, Jeremy D. Young, Sandra A. Springer

Published in: AIDS and Behavior | Issue 10/2017

Login to get access

Abstract

The U.S. female criminal justice (CJ) population is rapidly growing, yet large-scale studies exploring gender-specific HIV risk behaviors in the CJ population are lacking. This analysis uses baseline data on adults with a CJ history from eight U.S. studies in an NIH-funded “Seek, Test, Treat, Retain” harmonization consortium. Data were collected using a standardized HIV risk behavior assessment tool and pooled across studies to describe participants’ characteristics and risk behaviors. Multilevel mixed-effects logistic regression models were used to test for gender-based behavior differences. Among 784 HIV-positive (21.4% female) and 5521 HIV-negative (8.5% female) participants, HIV-positive women had higher odds than HIV-positive men of engaging in condomless sexual intercourse (AOR 1.84 [1.16–2.95]) with potentially sero-discordant partners (AOR 2.40 [1.41–4.09]) and of sharing injection equipment (AOR 3.36 [1.31–8.63]). HIV risk reduction interventions targeting CJ-involved women with HIV are urgently needed as this population may represent an under-recognized potential source of HIV transmission.
Appendix
Available only for authorised users
Literature
1.
Carson AE. Prisoners in 2014. U.S. Department of Justice, Bureau of Justice Statistics: Bureau of Justice Statistics, National Prisoner Statistics Program, 1978–2014; 2015.
2.
Institute for Criminal Policy Research (ICPR). World Prison Brief: United States of America. London: Birbeck University of London; 2016.
3.
Walmsley R. World prison population list London. Colchester: International Centre for Prison Studies (ICPS), University of Essex; 2013.
4.
Pagliaro LA, Pagliaro AM. Sentenced to death? HIV infection and AIDS in prisons—current and future concerns. Can J Criminol. 1992;34(2):201–14.PubMed
5.
Altice FL, Mostashari F, Selwyn PA, Checko PJ, Singh R, Tanguay S, et al. Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(5):444–53.CrossRefPubMed
6.
7.
Maruschak LM. HIV in prisons, 2001–2010. Washington, DC: Bureau of Justice Statistics, U.S. Department of Justice; 2012.
8.
Minton TD, Ginder S, Brumbaugh SM, Smiley-McDonald H, Rohloff H. Census of jails: population changes, 1999–2013. Bureau of Justice Statistics and RTI International; 2015. Report No.: NCJ 248627.
9.
Walmsley R. World female imprisonment list. London: Institute for Criminal Policy Research (ICPR), Birbeck University of London; 2015.
10.
Bureau of Justice Statistics. Probation and parole in the United States, 2014. 2015. Contract No.: NCJ 249057.
11.
Staton-Tindall M, Leukefeld C, Palmer J, Oser C, Kaplan A, Krietemeyer J, et al. Relationships and HIV risk among incarcerated women. Prison J. 2007;87(1):143–65.CrossRef
12.
Staton-Tindall M, Frisman L, Lin HJ, Leukefeld C, Oser C, Havens JR, et al. Relationship influence and health risk behavior among re-entering women offenders. Women Health Issues. 2011;21(3):230–8.CrossRef
13.
Strathdee SA, West BS, Reed E, Moazen B, Azim T, Dolan K. Substance use and HIV among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S110–7.CrossRefPubMedPubMedCentral
14.
Tortu S, Beardsley M, Deren S, Davis WR. The risk of HIV infection in a national sample of women with injection drug-using partners. Am J Public Health. 1994;84(8):1243–9.CrossRefPubMedPubMedCentral
15.
McClelland GM, Teplin LA, Abram KM, Jacobs N. HIV and AIDS risk behaviors among female jail detainees: implications for public health policy. Am J Public Health. 2002;92(5):818–25.CrossRefPubMedPubMedCentral
16.
Abiona TC, Balogun JA, Adefuye AS, Sloan PE. Pre-incarceration HIV risk behaviours of male and female inmates. Int J Prison Health. 2009;5(2):59–70.CrossRefPubMed
17.
Salisbury EJ, Van Voorhis P. Gendered pathways: a quantitative investigation of women probationers’ paths to incarceration. Crim Justice Behav. 2009;36(6):541–66.CrossRef
18.
Simpson SS, Yahner JL, Dugan L. Understanding women’s pathways to jail: analysing the lives of incarcerated women. Aust N Z J Criminol. 2008;41(1):84–108.CrossRef
19.
Fuentes CM. Nobody’s child: the role of trauma and interpersonal violence in women’s pathways to incarceration and resultant service needs. Med Anthropol Q. 2014;28(1):85–104.CrossRefPubMed
20.
Chen JL, Callahan DB, Kerndt PR. Syphilis control among incarcerated men who have sex with men: public health response to an outbreak. Am J Public Health. 2002;92(9):1473–4.CrossRefPubMedPubMedCentral
21.
Dissabandara LO, Dias SR, Dodd PR, Stadlin A. Patterns of substance use in male incarcerated drug users in Sri Lanka. Drug Alcohol Rev. 2009;28(6):600–7.CrossRefPubMed
22.
Feaster DJ, Reznick OG, Zack B, McCartney K, Gregorich SE, Brincks AM. Health status, sexual and drug risk, and psychosocial factors relevant to postrelease planning for HIV + prisoners. J Correct Health Care. 2013;19(4):278–92.CrossRefPubMedPubMedCentral
23.
Harwell TS, Trino R, Rudy B, Yorkman S, Gollub EL. Sexual activity, substance use, and HIV/STD knowledge among detained male adolescents with multiple versus first admissions. Sex Transm Dis. 1999;26(5):265–71.CrossRefPubMed
24.
Seal DW, Eldrige GD, Kacanek D, Binson D, Macgowan RJ, Project SSG. A longitudinal, qualitative analysis of the context of substance use and sexual behavior among 18- to 29-year-old men after their release from prison. Soc Sci Med. 2007;65(11):2394–406.CrossRefPubMed
25.
Stephenson BL, Wohl DA, McKaig R, Golin CE, Shain L, Adamian M, et al. Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS. 2006;17(2):103–8.CrossRefPubMed
26.
Grinstead O, Zack B, Faigeles B. Reducing postrelease risk behavior among HIV seropositive prison inmates: the health promotion program. AIDS Educ Prev. 2001;13(2):109–19.CrossRefPubMed
27.
Alarid LF, Hahl JM. Seroconversion risk perception among jail populations: a call for gender-specific HIV prevention programming. J Correct Health Care. 2014;20(2):116–26.CrossRefPubMed
28.
Adams LM, Kendall S, Smith A, Quigley E, Stuewig JB, Tangney JP. HIV risk behaviors of male and female jail inmates prior to incarceration and one year post-release. AIDS Behav. 2013;17(8):2685–94.CrossRefPubMedPubMedCentral
29.
Oser CB, Leukefeld CG, Tindall MS, Havens JR, Webster JM, Smiley-McDonald HM, et al. Male and female rural probationers: HIV risk behaviors and knowledge. AIDS care. 2006;18(4):339–44.CrossRefPubMed
30.
Farel CE, Parker SD, Muessig KE, Grodensky CA, Jones C, Golin CE, et al. Sexuality, sexual practices, and HIV risk among incarcerated African-American women in North Carolina. Women Health Issues. 2013;23(6):e357–64.CrossRef
31.
Chandler RK, Kahana SY, Fletcher B, Jones D, Finger MS, Aklin WM, et al. Data collection and harmonization in HIV research: the seek, test, treat, and retain initiative at the national institute on drug abuse. Am J Public Health. 2015;105(12):2416–22.CrossRefPubMed
32.
Amico KR, Fisher WA, Cornman DH, Shuper PA, Redding CG, Konkle-Parker DJ, et al. Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr. 2006;42(4):455–9.CrossRefPubMed
33.
Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, Friedland GH. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41(1):44–52.CrossRefPubMed
34.
Di Paola A, Lincoln T, Skiest DJ, Desabrais M, Altice FL, Springer SA. Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community. Contemp Clin Trials. 2014;39(2):256–68.CrossRefPubMedPubMedCentral
35.
Loeliger KB, Biggs ML, Seal DW, Gordon MS, Beckwith CG, Kuo I, et al. Gender differences in sexual risk behaviors among HIV-infected and uninfected persons involved in the U.S. criminal justice system: the STTR harmonization project. National HIV Prevention Conference; December 6–9 2015.
36.
Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.CrossRefPubMed
37.
Riley RD, Lambert PC, Staessen JA, Wang J, Gueyffier F, Thijs L, et al. Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med. 2008;27(11):1870–93.CrossRefPubMed
38.
Kontopantelis E, Reeves D. A short guide and a forest plot command (ipdforest) for one-stage meta-analysis. Stata J. 2013;13(3):574–87.
39.
Meyer JP, Springer SA, Altice FL. Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Women Health. 2011;20(7):991–1006.CrossRef
40.
Singer M (ed). Introduction to syndemics: a critical systems approach to public and community health. 1st ed, Hoboken: Wiley; 2009.
41.
Loeliger KB, Marcus R, Wickersham JA, Pillai V, Kamarulzaman A, Altice FL. The syndemic of HIV, HIV-related risk and multiple co-morbidities among women who use drugs in Malaysia: important targets for intervention. Addict Behav. 2015;53:31–9.CrossRefPubMedPubMedCentral
42.
43.
44.
El-Bassel N, Gilbert L, Witte S, Wu E, Chang M. Intimate partner violence and HIV among drug-involved women: contexts linking these two epidemics—challenges and implications for prevention and treatment. Subst Use Misuse. 2011;46(2–3):295–306.CrossRefPubMed
45.
El-Bassel N, Witte SS, Wada T, Gilbert L, Wallace J. Correlates of partner violence among female street-based sex workers: substance abuse, history of childhood abuse, and HIV risks. AIDS Patient Care STDs. 2001;15(1):41–51.CrossRefPubMed
46.
Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66(4):911–21.CrossRefPubMed
47.
Wechsberg WM, Luseno W, Ellerson RM. Reaching women substance abusers in diverse settings: stigma and access to treatment 30 years later. Subst Use Misuse. 2008;43(8–9):1277–9.CrossRefPubMed
48.
Knudsen HK, Leukefeld C, Havens JR, Duvall JL, Oser CB, Staton-Tindall M, et al. Partner relationships and HIV risk behaviors among women offenders. J Psychoact Drugs. 2008;40(4):471–81.CrossRef
49.
Kuo C, Johnson J, Rosen RK, Wechsberg W, Gobin RL, Reddy MK, et al. Emotional dysregulation and risky sex among incarcerated women with a history of interpersonal violence. Women Health. 2014;54(8):796–815.CrossRefPubMedPubMedCentral
50.
Bergmann JN, Stockman JK. How does intimate partner violence affect condom and oral contraceptive Use in the United States?: a systematic review of the literature. Contraception. 2015;91(6):438–55.CrossRefPubMedPubMedCentral
51.
MacRae R, Aalto E. Gendered power dynamics and HIV risk in drug-using sexual relationships. AIDS Care. 2000;12(4):505–15.CrossRefPubMed
52.
Sherman SG, Latkin CA, Gielen AC. Social factors related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse. 2001;36(14):2113–36.CrossRefPubMed
53.
Tortu S, McMahon JM, Hamid R, Neaigus A. Women’s drug injection practices in East Harlem: an event analysis in a high-risk community. AIDS Behav. 2003;7(3):317–28.CrossRefPubMed
54.
Wagner KD, Bloom JJ, Hathazi SD, Sanders B, Lankenau SE. Control over drug acquisition, preparation and injection: implications for HIV and HCV risk among young female injection drug users. ISRN Addict. 2013. doi:10.​1155/​2013/​250751.PubMedPubMedCentral
55.
Battjes RJ, Pickens RW, Haverkos HW, Sloboda Z. HIV risk factors among injecting drug users in five US cities. AIDS. 1994;8(5):681–7.CrossRefPubMed
56.
Peles E, Adelson M. Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic. J Addict Dis. 2006;25(2):39–45.CrossRefPubMed
57.
Springer SA, Larney S, Alam-Mehrjerdi Z, Altice FL, Metzger D, Shoptaw S. Drug treatment as HIV prevention among women and girls who inject drugs from a global perspective: progress, gaps, and future directions. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S155–61.CrossRefPubMedPubMedCentral
58.
Valleroy LA, MacKellar DA, Karon JM, Rosen DH, McFarland W, Shehan DA, et al. HIV prevalence and associated risks in young men who have sex with men. JAMA. 2000;284(2):198–204.CrossRefPubMed
59.
McKeganey N, Barnard M. AIDS, drugs, and sexual risk: lives in the balance. Philadelphia: Open University Press; 1992.
60.
Anderson RM, May RM. Epidemiological parameters of HIV transmission. Nature. 1988;333(6173):514–9.CrossRefPubMed
61.
UNAIDS Joint United Nations Programme on HIV/AIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. 2014.
62.
Metsch L, Philbin MM, Parish C, Shiu K, Frimpong JA, le Giang M. HIV testing, care, and treatment among women who use drugs from a global perspective: progress and challenges. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S162–8.CrossRefPubMedPubMedCentral
63.
Meyer JP, Cepeda J, Taxman FS, Altice FL. Sex-related disparities in criminal justice and HIV treatment outcomes: a retrospective cohort study of HIV-infected inmates. am j public Health. 2015;105(9):1901–10.CrossRefPubMedPubMedCentral
64.
Epperson MW, Khan MR, Miller DP, Perron BE, El-Bassel N, Gilbert L. Assessing criminal justice involvement as an indicator of human immunodeficiency virus risk among women in methadone treatment. J Subst Abuse Treat. 2010;38(4):375–83.CrossRefPubMedPubMedCentral
65.
Swartz JA, Lurigio AJ, Weiner DA. Correlates of HIV-risk behaviors among prison inmates: implications for tailored aids prevention programming. Prison J. 2004;84(4):486–504.CrossRef
66.
Metzger DS, Zhang Y. Drug treatment as HIV prevention: expanding treatment options. Current HIV/AIDS Rep. 2010;7(4):220–5.CrossRef
67.
68.
Gollub EL. A neglected population: drug-using women and women’s methods of HIV/STI prevention. AIDS Educ Prev. 2008;20(2):107–20.CrossRefPubMed
69.
Weir BW, O’Brien K, Bard RS, Casciato CJ, Maher JE, Dent CW, et al. Reducing HIV and partner violence risk among women with criminal justice system involvement: a randomized controlled trial of two motivational interviewing-based interventions. AIDS Behav. 2009;13(3):509–22.CrossRefPubMed
70.
Jiwatram-Negron T, El-Bassel N. Systematic review of couple-based HIV intervention and prevention studies: advantages, gaps, and future directions. AIDS Behav. 2014;18(10):1864–87.CrossRefPubMedPubMedCentral
71.
Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.CrossRefPubMedPubMedCentral
72.
Althoff AL, Zelenev A, Meyer JP, Fu J, Brown SE, Vagenas P, et al. Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav. 2013;17(Suppl 2):S156–70.CrossRefPubMed
73.
Pinkham S, Malinowska-Sempruch K. Women, harm reduction and HIV. Reprod Health Matters. 2008;16(31):168–81.CrossRefPubMed
74.
Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089–102.CrossRefPubMed
75.
Springer SA. Commentary on Larney (2010): a call to action-opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid-dependent prisoners. Addiction. 2010;105(2):224–5.CrossRefPubMedPubMedCentral
76.
Springer SA, Azar MM, Altice FL. HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse. 2011;37(1):12–21.CrossRefPubMed
77.
Springer SA, Qiu J, Saber-Tehrani AS, Altice FL. Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PLoS ONE. 2012;7(5):e38335.CrossRefPubMedPubMedCentral
78.
Malinowska-Sempruch K. What interventions are needed for women and girls who use drugs? A global perspective. J Acquir Immune Defic Syndr. 2015;69(Suppl 1):S96–7.CrossRefPubMed
79.
Gilbert L, Raj A, Hien D, Stockman J, Terlikbayeva A, Wyatt G. Targeting the SAVA (substance abuse, violence, and AIDS) syndemic among women and girls: a global review of epidemiology and integrated interventions. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S118–27.CrossRefPubMedPubMedCentral
80.
El-Bassel N, Strathdee SA. Women who use or inject drugs: an action agenda for women-specific, multilevel, and combination HIV prevention and research. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S182–90.CrossRefPubMedPubMedCentral
Metadata
Title
Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV: A “Seek, Test, Treat, and Retain” Harmonization Consortium
Authors
Kelsey B. Loeliger
Mary L. Biggs
Rebekah Young
David W. Seal
Curt G. Beckwith
Irene Kuo
Michael S. Gordon
Frederick L. Altice
Lawrence J. Ouellet
William E. Cunningham
Jeremy D. Young
Sandra A. Springer
Publication date
01-10-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 10/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1722-9

Other articles of this Issue 10/2017

AIDS and Behavior 10/2017 Go to the issue

Original Paper

Sexual Partner Concurrency Among Partners Reported by MSM with Recent HIV Infection

Original Paper

Predictors of HIV Risk Behaviors Among a National Sample of Russian Men Who Have Sex with Men

Original Paper

Place-Based Predictors of HIV Viral Suppression and Durable Suppression Among Men Who Have Sex With Men in New York City

Original Paper

Implementation of Evidence-Based HIV Interventions for Gay, Bisexual, and Other Men Who Have Sex with Men

Original Article

Identifying Patterns of Social and Economic Hardship Among Structurally Vulnerable Women: A Latent Class Analysis of HIV/STI Risk

Substantive Review

Identifying Resilience Resources for HIV Prevention Among Sexual Minority Men: A Systematic Review

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits